Inverse association between macronutrient quality index and renal cancer incidence: results from the prostate, lung, colorectal, and ovarian cancer screening trial
Frontiers in Public Health · 16.11.2026 · 14
DOI: 10.3389/fpubh.2026.2000980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 16.11.2026. Verfasst von Lulu Zhou und 5 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The quality of dietary macronutrients, as an integrated measure of dietary patterns, has been increasingly recognized for its potential role in cancer prevention. However, prospective evidence regarding its association with renal cancer incidence and mortality remains limited. We conducted a large-scale prospective cohort study using data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial to investigate the relationships between the macronutrient quality index (MQI) and renal cancer risk and survival.
Methods
A total of 101,755 participants aged 55–74 years from 10 U.S. screening centers were included. The MQI was derived from a validated dietary history questionnaire, reflecting overall macronutrient quality. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between MQI and renal cancer incidence, with renal cancer mortality as a secondary endpoint. Sensitivity and subgroup analyses were performed to ensure robustness.
Results
Over a mean follow-up of 8.82 ± 1.95 years (897,809 person-years), 446 incident renal cancer cases were documented. In the fully adjusted model, participants in the highest MQI quartile had a significantly lower risk of renal cancer incidence compared with the lowest quartile (HR Q4 vs. Q1: 0.72; 95% CI: 0.54–0.96; P-trend = 0.032). Sensitivity and subgroup analyses confirmed the robustness of this inverse association. For renal cancer mortality (113 deaths), the association did not reach statistical significance (HR Q4 vs. Q1: 0.70; 95% CI: 0.38–1.29; P-trend = 0.422).
Conclusion
A higher macronutrient quality index is associated with a reduced risk of renal cancer in U.S. middle-aged and older adults (predominantly White participants of the PLCO trial). However, the association with renal cancer mortality was not statistically significant, which may be attributable to the limited number of fatal events and the resulting low statistical power. Further investigation in larger cohorts is warranted.
Zitieren
APA
Zhou, L., Xie, S., Luo, Y., Peng, L., Feng, D., & Peng, J. (2026). Inverse association between macronutrient quality index and renal cancer incidence: results from the prostate, lung, colorectal, and ovarian cancer screening trial. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.2000980
Vancouver
Zhou L, Xie S, Luo Y, Peng L, Feng D, Peng J. Inverse association between macronutrient quality index and renal cancer incidence: results from the prostate, lung, colorectal, and ovarian cancer screening trial. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.2000980
BibTeX
@article{Zhou2026,
author = {Zhou, Lulu and Xie, Shouguang and Luo, Yuxiang and Peng, Linglong and Feng, Dazhan and Peng, Jingluo},
title = {Inverse association between macronutrient quality index and renal cancer incidence: results from the prostate, lung, colorectal, and ovarian cancer screening trial},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.2000980}
}
EUVIMED